Serum cytokines in juvenile rheumatoid arthritis: correlation with conventional inflammation parameters and clinical subtypes

Arthritis & Rheumatism

Volumn 38, Issue 2, 1995, Pages 211-220

  Mangge, Harald ^a   Kenzian, Harald ^a   Gallistl, Siegfried ^a   Neuwirth, Gudrun ^a   Liebmann, Peter ^a   Kaulfersch, Wilhelm ^a   Beaufort, Friedrich ^a   Muntean, Wolfgang ^a   Schauenstein, Konrad ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; RECOMBINANT INTERLEUKIN 2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEMOGLOBIN ANALYSIS; HUMAN; IRON BLOOD LEVEL; JUVENILE RHEUMATOID ARTHRITIS; LEUKOCYTE COUNT; MALE; PATIENT MONITORING; PRIORITY JOURNAL; THROMBOCYTE COUNT;

EID: 0028816371     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780380209     Document Type: Article

References (32)

1. Cytokines and anti‐cytokines
2. Serum levels of interleukin‐1β, tumor nercrosis factor‐α and interleukin‐2 in rheumatoid arthritis: correlation with disease activity
3. Cytokines and soluble interleukin 2 receptors in rheumatoid arthritis
4. Serum IL‐2 level in rheumatoid arthritis: correlation with joint destruction and disease progression
5. Cytokines in rheumatoid arthritis
6. Interleukin‐6, soluble interleukin‐2 receptor and microheterogeneity of alpha‐acid glycoprotein: new markers of the acute‐phase reaction
7. Cytokine interrelationships and their association with disease activity in arthritis
8. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases
9. Levels of circulating tumor necrosis factor α and interleukin‐6 in patients with rheumatoid arthritis: relationship to serum levels of hyaluronan and antigenic keratan sulfate
10. Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum
11. Interleukin‐6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides
12. Cytokines in autoimmunity
13. Soluble interleukin‐2 receptor is unhelpful in chronic inflammatory rheumatism
14. Temporal covariation of soluble interleukin‐2 receptor levels, daily stress, and disease activity in rheumatoid arthritis
15. Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue
16. Profile of cytokines in synovial fluid specimens from patients with arthritis: interleukin‐8 (IL‐8) and IL‐6 correlate with inflammatory arthritides
17. Inflammatory cytokines and enzymes in synovial fluid of patients with rheumatoid arthritis and other arthritides
18. Soluble tumor necrosis factor receptors in human inflammatory synovial fluids
19. Interleukin‐8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate
20. Current proposed revision of JRA criteria
21. Juvenile rheumatoid arthritis
22. Cytokines in childhood rheumatic diseases
23. Validity and reliability of joint indices: a longitudinal study in patients with recent onset rheumatoid arthritis
24. Specific interleukin 1 inhibitor in serum and urine of children with systemic JCA
25. Soluble interleukin‐2 receptors in children with juvenile chronic arthritis
26. Lymphokines and soluble interleukin‐2 receptors in juvenile chronic arthritis: clinical and laboratory correlations
27. Correlation of serum interleukin‐6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis
28. Interleukin‐6: an overview
29. Increased levels of soluble tumor necrosis factor receptor in patients with multiple sclerosis and HTLV‐1‐associated myelopathy
30. Immune abnormalities in the pathogenesis of juvenile rheumatoid arthritis
31. Multiple inhibitors of mitogen‐induced proliferation of normal lymphocytes in juvenile chronic arthritis sera
32. Immunoregulatory defects in juvenile rheumatoid arthritis: comparison between patients with the systemic or polyarticular forms